Summary. Pro-opiomelanocortin (POMC) mRNA was detected on paraffin sections by in situ hybridization (ISH) in corticotrophs of 12 nontumorous pituitaries, 11 functioning corticotroph, and 11 silent pituitary adenomas. ISH combined with immunocytochemistry for adrenocorticotrophic hormone (ACTH), a POMC-derived peptide, was also performed. ACTH immunoreactive cells of the anterior lobes and those invading the posterior lobe showed a high or moderate level of POMC mRNA that was not correlated with the intensity of ACTH immunoreactivity. Variable levels of POMC gene expression were present in Crooke's cells, corticotrophs suppressed by glucocorticoid excess. Most functioning corticotroph adenomas and silent subtype 1 adenomas had an intense hybridization signal and ACTH immunoreactivity. In silent subtype 2 and 3 adenomas, POMC mRNA had a diffuse low level or was absent; in these adenomas ACTH immunoreactivity was diffuse, restricted to some cells, or negative. The results indicate that POMC gene is expressed in both normal and suppressed nontumorous corticotrophs. Intense signals for POMC mRNA are found in most functioning corticotroph adenomas. The difference between POMC gene expression in silent 1 and silent 2 and 3 adenomas suggests that different mechanisms are responsible for the lack of endocrine activity.
Introduction
The pituitary corticotroph is the major site of pro-opiomelanocortin (POMC) gene expression in man. In this cell type, the POMC molecule is processed post-transla- Most of the tumors arising in corticotrophs are associated with Cushing's disease or Nelson's syndrome due to increased production of ACTH. Electron microscopy shows that functioning corticotroph adenomas consist of well-differentiated, densely granulated cells. A few cases represent sparsely granulated, less differentiated adenomas or adenomas with Crooke's hyalinization (Kovacs and Horvath 1986; . Some corticotroph adenomas are not associated with endocrine symptoms and, based on their ultrastructural features, have been divided into three subtypes: silent subtype 1 possesses an ultrastructure similar to that of the functioning variant; silent subtype2 has small, spherical, tear-and heart-shaped granules of 150-450 nm and is devoid of microfilaments; silent subtype 3 tumors contain abundant RER and SER profiles, very prominent, multifocal Golgi apparatus, small secretory granules (< 200 nm) and nuclei with spheridia (Kovacs et al. 1978; Horvath et al. 1980; Hassoun et al. 1982; . The mechanisms responsible for the lack of ACTH excess in patients with such tumors are unknown. The investigation of POMC gene expression in nontumorous corticotrophs and their adenomas can contribute to a better understanding of the molecular events involved in hormone production.
The human POMC gene has been cloned and its DNA sequence determined (Chang et al. 1980; Whitfeld et al. 1982) . In the pituitary, POMC mRNA has been : detected by Northern blot and/or in situ hybridization (ISH) (Kelsey et al. 1986; Lewis etal. 1986; DeBold et al. 1988; Farquharson et al. 1990; Lloyd 1990) . The usefulness of the ISH method for POMC mRNA demonstration in both functioning and silent corticotroph adenomas, using archival, paraffin-embedded specimens, has been proven by Lloyd et al. (1990) .
In the present study, the presence of POMC mRNA was investigated in nontumorous corticotrophs and all types of corticotroph adenomas and compared with their ACTH immunoreactivity and ultrastructural features.
Materials and methods
Tissues. Nontumorous pituitaries were obtained at autopsy (5 cases) of patients dying of nonendocrine diseases and at surgery of patients with the diagnosis of Cushing's disease (7 cases). Corticotroph adenomas were removed at surgery from patients with Cushing's disease (8 cases) and Nelson's syndrome (3 cases). Silent corticotroph adenomas included subtype 1 (4 cases), subtype 2 (3 cases) and subtype 3 (4 cases). All adenomas were previously diagnosed based on clinical, histologic, immunocytochemical and electron microscopic data.
Pieces of tumors were fixed in 10% buffered formalin and embedded in paraffin. Five-micron-thick sections were mounted on 3-aminopropylmethoxysilane-coated slides.
Probes. For POMC mRNA demonstration, an oligonucleotide probe (NEP-20/4, Dupont Canada Inc. Mississauga, Ont.) of 30 nucleotides (5'-d(CTT-GCC-CCA-GCG-GAA-GTG-CTC-CAT-GGA-GTA(-3') was used. As positive-control probe, oligodeoxythymidylates, p(dT) 19-24 (The Midland Certified Reagent Co., Midland, Tex, USA) that detects poly-adenylated RNA sequences (Pringle et al. 1989 ) was applied. The probes were labeled by the T-end method with (35S)dATPc~ S and terminal deoxynucleotidyl transferase using a kit (NEP-100, Dupont Canada Inc. Mississauga, Ont.) and purified with NENSORBTU20 cartridge included in the kit.
In situ hybridization. ISH was carried out on paraffin sections applying 3 • 105 CPM of POMC probe and I • 106 p(dT) probe as described previously (Kovacs et al. J1989; Lloyd et al. 1990 ). For ISH combined with immunocytochemistry, the avidin-biotin-peroxidase complex (ABC) method for ACTH was applied after 2 x SSC washings. Anti-hACTH (NIDDKD, Bethesda, Md., diluted 1:2000, was used. Autoradiography was done with NTB-2 emulsion, diluted 1 : 1 with distilled water containing 0.3 M ammonium acetate, as previously described (Kovacs et al. 1989) . Slides were exposed to emulsion for 1 week at 4 ~ C and then developed.
The specificity of hybridization was checked by: (1)predigestion of tissue sections with 100 ng/ml RNase A (Sigma, St. Louis, MO, USA); (2) competition study with tenfold excess of unlabeled probe; (3) human kidney used as negative control.
labeling prevailed (Fig. 4) . Moderate densities of silver grains were noted in two adenomas, which contained not only ACTH but TSH and ~-SU of glycoprotein hormones immunoreactivities in a few cells (case 4) or only c~-SU in many cells (case 5). A moderate signal intensity was also present in a sparsely granulated corticotroph adenoma, an adenoma composed of large Crooke's cell population, and small cell population with signs of suppression and in an atypical corticotroph adenoma. The latter tumor was composed of small cells with moderately developed rough endoplasmic reticulum (RER) and Golgi regions; the small secretory granules (150--300 nm) with ovoid, rod, and heart shape were confined to the cell periphery; some adenoma cells showed extensive hyalinization. In functioning corticotroph adenomas associated with Nelson's syndrome, an intense or weak signal was present (Fig. 5) . In functioning corticotroph tumors, the level of POMC gene expression could not be correlated with the amount of microfilaments in adenoma cells (Table 1) .
In silent subtype 1 corticotroph adenomas, the intensity of labeling was similar to that encountered in functioning adenomas (Fig. 6) . A low level or absence of POMC gene expression was found in silent subtype 2 adenomas (Fig. 7 A) . The silver granules were evenly distributed among adenoma cells despite the focal ACTH immunoreactivity. In silent subtype 3 adenomas, POMC mRNA presented a low level in one case with diffuse immunoreactivity for ACTH; three cases were negative for POMC mRNA; one adenoma exhibited scattered ACTH immunoreactive cells; a variable number of cells immunoreactive for other adenohypophysial hormones was present in all three silent subtype 3 adenomas (Table 2).
The detection of poly-adenylated RNA in adenomas indicated the preservation of mRNA in formalin-fixed paraffin sections (Fig. 7 B) . However, the intensity of hybridization signal was not quantified since no information was available on the fixation and processing times of specimens. It is known that in paraffin-embedded tissue, a decrease in the mRNA amount occurs, depending on the duration of fixation and other parameters.
Results
In nontumorous pituitaries, the corticotrophs exhibited high levels of labeling for POMC mRNA (Fig. 1) , which could not be correlated with the intensity of ACTH immunostaining. The corticotrophs extending into the posterior lobe expressed POMC mRNA as well (Fig. 2) . The signal intensity was comparable or slightly lower than in the anterior lobe. The cells lining cavities representing pars intermedia labeled intensely for POMC mRNA.
Crooke's cells, found in nontumorous pituitaries obtained at surgery in association with functioning corticotroph adenomas, contained moderate to low levels of POMC mRNA (Fig. 3) . A higher amount of labeling was found in Crooke's cells of autopsy pituitaries.
All functioning corticotroph adenomas expressed POMC mRNA. In well-differentiated, densely granulat-
Discussion
Anterior pituitary corticotrophs are exposed to stimulatory and inhibitory control, mediated by hypothalamic and other factors and by direct glucocorticoid feedback from the adrenal gland (Keller-Wood and Dallman 1984; Lundbad and Roberts 1988) . Long-term treatment with corticotropin-releasing hormone (CRH) or glucocorticoids have a direct influence on the synthesis and release of ACTH and other POMC-derived peptides (reviewed by Lundbad and Roberts 1988) . The molecular mechanisms of transcriptional activation and inhibition of POMC gene are poorly understood.
The POMC mRNA can be demonstrated histologically by ISH methods. The comparison of ISH results with those of dot blot quantitation proved that ISH is an appropriate technic for detecting mRNAs both cytologically and quantitatively (Lewis et al. 1986 ). In nontumorous pituitaries ISH analysis combined with immunocytochemistry revealed that a high level of POMC mRNA was present in most ACTH immunoreactive cells, including those lining cavities of the intermediate lobe and those invading the posterior lobe. Variable amounts of POMC mRNA were found in Crooke's cells, which are corticotrophs suppressed due to glucocorticoid excess. The glucocorticoid feedback inhibition of ACTH release is rapid and progressive. The so-called delayed feedback occurs over hours to days and is accompanied by unresponsiveness to CRF and marked decreases in mRNA (Birnberg et al. 1983) . Depending on the duration, glucocorticoid exposure can induce total unresponsiveness of the hypothalamic-pituitary-adrenal axis to extreme stimuli, as observed in partients with Cushing's syndrome or long-term therapeutic exposure to glucocorticoids (Jones 1979; Keller-Wood and Dallman 1984) . In the human pituitary, the Crooke's cells are readily identified due to massive, ring-like accumulation of filaments. A few bundles of such filaments, measuring approximately 70 nm in width and representing cytokeratins disposed mainly around the nucleus, are unique morphologic markers of normal and suppressed human corticotrophs. In Crooke's cells, found in nontumorous adenohypophyses adjacent to a functioning corticotroph adenoma, low to moderate amounts of hybridization signal were detected, indicating that POMC gene transcription is not completely inhibited in such cells. In the corticotrophs with Crooke's change found in autopsy pituitaries, the signal intensity was comparable to that of normal corticotrophs. Since we do not have any data about the duration of glucocorticoid medication in these patients, the results cannot be assessed. Crooke's hyalinization is a reversible change that gradually disappears after normalization of blood glucocorticoid levels.
In most functioning corticotroph adenomas, a high level of POMC mRNA was identified. This is not surprising since it is known that in such tumors the feedback inhibition of ACTH by glucocorticoids is defective and that the elevated plasma cortisol does not decrease ACTH secretion. A lower POMC gene expression was observed in some rarely occurring corticotroph adenomas, such as the sparsely granulated variant, an atypical adenoma and an adenoma composed of two cell populations, a small cell component with scanty RER, inconspicuous Golgi regions and small secretory gran- . In adenomas associated with Cushing's disease and Nelson's syndrome, the intensity of hybridization was not correlated with the amount of microfilaments present in adenoma cells in different cases.
In silent subtype 1 corticotroph adenomas, the level of POMC mRNA was comparable to that seen in functioning corticotroph adenomas. The ACTH immunoreactivity and the intensity of hybridization signal were evenly distributed among adenoma cells regardless of the percentage of cells with Crooke's change. Our results are in agreement with those of Lloyd et al. (1990) and suggest that, in this type of silent adenoma, the hormone synthesis is not inhibited at the transcription level. One can speculate that in such tumors a defective mechanism of POMC processing or peptides release exists. Abnormal processing of precursor peptide caused by point mutation(s) in POMC mRNA is one possibility. However, in one silent corticotroph adenoma, Nagaya et al. (1990) could not identify any abnormality in POMC size and coding sequence. In some corticotroph adenomas, gel chromatography analysis demonstrated the predominant secretion of a high molecular weight ACTH with a low biologic activity. In such tumors, the hormone release was not disturbed and the patients presented with or without Cushing's disease (Fuller et al. 1984; Reincke et al. 1987) .
In silent subtype 2 and 3 adenomas, the POMC gene transcription was consistently low, indicating that a reduced rate of hormone synthesis can be responsible for the lack of endocrine symptoms. Morphologically, silent subtype 2 adenomas have some ultrastructural features of corticotrophs, such as the shape of cell and secretory granules, but they lack type 1 microfilaments; ACTH immunoreactivity is present in a variable number of cells. Silent subtype 3 adenomas initially were included in the group of corticotroph adenomas due to their immunoreactivity for ACTH and other POMC-derived peptides (Horvath et al. 1980) . As more cases were investigated, it became evident that some adenomas contained no ACTH, and focal immunopositivity for other hormones was a frequent finding. Since silent subtype 3 adenoma is a well-defined entity by electron microscopy with no features reminiscent of corticotrophs, it is at present considered a separate group and its cellular origin remains obscure ). In situ hybridization studies indicate a low amount of POMC mRNA or none at all in silent subtype 3 adenomas. PRL gene expression was found in one case of silent subtype 3 tumor by Lloyd et al. (1990) . The application of probes for glycoprotein hormones may contribute to prove the suggested potential of multidirectional differentiation of these tumors.
